Effect of benidipine hydrochloride, a long-acting T-type calcium channel blocker, on blood pressure and renal function in hypertensive patients with diabetes mellitus: Analysis after switching from cilnidipine to benidipine

Arzneimittel-Forschung/Drug Research

Volumn 57, Issue 8, 2007, Pages 526-531

  Seino, Hiroaki ^a   Miyaguchi, Shuichi ^b   Yamazaki, Toshiro ^b   Ota, Setsu ^b   Yabe, Ryuji ^b   Suzuki, Susumu ^b  

^a Seino Internal Clinic   (Japan)

^b OHTA NISHINOUCHI HOSPITAL   (Japan)

Author keywords

Benidipine hydrochloride, antihypertensive effect, renoprotective effect; Calcium channel blockers, T type calcium channel; CAS 132203 70 4; CAS 91599 74 5; Coniel ; Diabetes mellitus, hypertensive patients

Indexed keywords

BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL T TYPE; CILNIDIPINE; LONG ACTING DRUG;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; OUTCOME ASSESSMENT; PROTEIN URINE LEVEL; RENAL PROTECTION; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 34548841121     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296643     Document Type: Article

References (31)

1. Kitagawa M, Seino H, Yamaguchi H, et al. Relation of plasma glucose levels, blood pressure and complication in patients with diabetes mellitus for 20 years or over. Ohta Nishinouchi Hospital Annual Reports 2002;37:1-8
2. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755-1762
3. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412-419
4. Japanese Society of Hypertension Guidelines Committee. Guidelines for the Management of Hypertension (JSH2004). Tokyo: Life Science; 2004. p. 47-49.
5. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053
6. Baba S, J-MIND Study Group. Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics. Diabetes Res Clin Pract. 2001;54:191-201.
7. Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. NEJM. 1999;340:677-684.
8. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
9. Catterall WA. Structure and regulation of voltage-gated Ca2+ channels. Ann Rev Cell Dev Biol. 2000;16:521-555.
10. Hayashi K, Wakino S, Homma K, Sugano N, Saruta T. Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation. J Pharmacol Sci. 2005;99:221-227.
11. Feng MG, Navar LG. Angiotensin II-mediated constriction of afferent and efferent arterioles involves T-type Ca2+ channel activation. Am J Nephrol. 2004;24:641-648.
12. Hansen PB, Jensen BL, Andreasen D, Skott O. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels. Circ Res. 2001;89:630-638.
13. Fujii S, Kameyama K, Hosono M, Hayashi Y, Kitamura K. Effect of cilnidipine, a novel dihydropyridine calcium channel blocker, on N-type calcium channel in rat dorsal root ganglion neurons. J Pharmacol Exp Ther. 1997;280:1184-1191.
14. Uneyama H, Takahara A, Dohmoto H, Yoshimoto R, Inoue K, Akaike N. Blockade of N-type Ca2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones. Br J Pharmacol. 1997;122:37-42.
15. Hosono M, Fujii S, Hiruma T, Watanabe K, Hayashi Y, Ohnishi H, et al. Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats. Jap J Pharmacol. 1995;69:127-134.
16. Uzu T, Nishimura M, Fujii T, Sakaguchi M, Kanasaki M, Isshiki K, et al. Benidipine attenuates glomerular hypertension and reduces albuminuria in patients with metabolic syndrome. Hypertens Res. 2007;30:161-165.
17. Suzuki H, Saruta T, Calcium channel blocker in Progressive Renal Insufficiency Study Group. Effects of calcium channel blocker, benidipine, on the progression of chronic renal failure in the elderly: a 1-year follow-up. Clin Exp Hypertens (NY). 2001;23:189-201.
18. Yao K, Nagashima K, Miki H. Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker. J Pharmacol Sci. 2006;100:243-261.
19. Okumura M, Masada M, Yoshida Y, Shintaku H, Hosoi M, Okada N, et al. Decrease in tetrahydrobiopterin as a possible cause of nephropathy in type II diabetic rats. Kidney Int. 2006;70:471-476.
20. Furukawa T, Yamakawa T, Midera T, Sagawa T, Mori Y, Nukada T. Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes. J Pharmacol Exp Ther. 1999;291:464-473.
21. Furukawa T, Nukada T, Miura R, Ooga K, Honda M, Watanabe S, et al. Differential blocking action of dihydropyridine calcium channel blockers on a T-type calcium channel (alpha1G) expressed in Xenopus oocytes. J Cardiovasc Pharmacol. 2005;45:241-246.
22. Seino H, Miyaguchi S, Yamazaki T, Ota S, Saito M, Yabe R. Clinical effects of a long-acting calcium channel blocker, benidipine hydrochloride, on the hypertensive patients with diabetes mellitus. Retrospective large scale study of 345 patients. Endocrinol Diabetol 2006;22:371-378. [Japanese]
23. Yue W, Kimura S, Fujisawa Y, Tian R, Li F, Rahman M, et al. Benidipine dilates both pre- and post-glomerular arteriole in the canine kidney. Hypertens Res. 2001;24:429-436.
24. Kawata T, Hashimoto S, Koike T. Diversity in the renal hemodynamic effects of dihydropyridine calcium blockers in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1997;30:431-436.
25. Takeda K, Yamagishi R, Masumiya H, Tanaka H, Shigenobu K. Effect of cilnidipine on L- and T-type calcium currents in guinea pig ventricle and action potential in rabbit sinoatrial node. J Pharmacol Sci. 2004;95:398-401.
26. Konda T, Enomoto A, Takahara A, Yamamoto H. Effects of L/N-type calcium channel blocker, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats. Biol Pharm Bull. 2006;29:933-937.
27. Zhan Y, Kim S, Kawano H, Iwao H. Enhancement of glomerular platelet-derived growth factor beta-receptor tyrosine phosphorylation in hypertensive rats and its inhibition by calcium channel blocker. Hypertens Res Clin Exp. 2002;25:295-301.
28. Nomura M, Nakaya Y, Uemura E, Sawa Y, Iga A, Kageyama N, et al. Effects of benidipine hydrochloride on autonomic nervous activity in hypertensive patients with high- and low-salt diets. Arzneimittel-Forschung (Drug Research). 2003;53:314-320.
29. Karasawa A, Nomura H, Nito M, Sonoda R, Tanaka H, Kosaka N, et al. Effects of benidipine hydrochloride on blood pressure, heart rate and plasma norepinephrine concentration in spontaneously hypertensive rats. Nippon Yakurigaku Zasshi [Folia Pharmacol Japon]. 1999;113:317-326. [Japanese]
30. Suzuki M, Kanazawa A, Hasegawa M, Harano Y. Improvement of insulin resistance in essential hypertension by long-acting Ca antagonist benidipine. Clin Exp Hypertens. 1999;21:1327-1344.
31. Higashiura K, Ura N, Takada T, Agata J, Yoshida H, Miyazaki Y, et al. Alteration of muscle fiber composition linking to insulin resistance and hypertension in fructose-fed rats. Am J Hypertens. 1999;12:596-602.